TFF (Trefoil Factor Family) is a novel tumor suppressor and can be the therapeutic target for pancreatic cancer

被引:0
|
作者
Yamaguchi, Junpei
Yokoyama, Yukihiro
Kokuryo, Toshio
Nagino, Masato
机构
关键词
D O I
10.1158/1538-7445.PANCA16-A67
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A67
引用
收藏
页数:2
相关论文
共 50 条
  • [1] The novel tumor suppressor Trefoil Factor Family 1 (TFF1) inhibits the development of hepatocellular carcinoma in mice
    Yamaguchi, Junpei
    Yokoyama, Yukihiro
    Kokuryo, Toshio
    Ebata, Tomoki
    Nagino, Masato
    HEPATOLOGY, 2017, 66 : 981A - 982A
  • [2] Trefoil factor family (TFF) peptides and cancer progression
    Emami, S
    Rodrigues, S
    Rodrigue, CM
    Le Floch, N
    Rivat, C
    Attoub, S
    Bruyneel, E
    Gespach, C
    PEPTIDES, 2004, 25 (05) : 885 - 898
  • [3] Mutations of trefoil factor family-1 (TFF1) reverse its tumor suppressor activity in human gastric cancer.
    Yio, XY
    Diamond, M
    Zhang, JY
    Werther, L
    Itzkowitz, S
    GASTROENTEROLOGY, 2005, 128 (04) : A107 - A107
  • [4] Integrated Analysis of Trefoil Factor Family Members in Breast Cancer: Tumor Suppressor or Oncogene?
    Ge, R.
    Li, J.
    Wang, G.
    Siddharth, S.
    Wu, Q.
    Chen, C.
    Zhu, S.
    Sun, S.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S204 - S204
  • [5] TFF1 (Trefoil Factor Family 1) act as Tumor Suppressor to Inhibit Invasive Transformation of PanIN Into PDAC In Vivo
    Yamaguchi, J.
    Yokoyama, Y.
    Kokuryo, T.
    Nagino, M.
    PANCREAS, 2016, 45 (10) : 1547 - 1547
  • [6] Mechanistic Implications of Trefoil Factor 1 (TFF1) in Pancreatic Cancer Chemoresistance
    Jahan, R.
    Ganguly, K.
    Smith, L. M.
    Sheikh, I. A.
    Sheinin, Y.
    Macha, M. A.
    Polland, M.
    Kaur, S.
    Batra, S. K.
    PANCREAS, 2018, 47 (10) : 1396 - 1396
  • [7] Depleted Tumor Suppressor miR-107 in Plasma Relates to Tumor Progression and Is a Novel Therapeutic Target in Pancreatic Cancer
    Imamura, Taisuke
    Komatsu, Shuhei
    Ichikawa, Daisuke
    Okajima, Wataru
    Ohashi, Takuma
    Kiuchi, Jun
    Nishibeppu, Keiji
    Ikoma, Hisashi
    Taniguchi, Hiroki
    Otsuji, Eigo
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : E120 - E120
  • [8] Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer
    Taisuke Imamura
    Shuhei Komatsu
    Daisuke Ichikawa
    Mahito Miyamae
    Wataru Okajima
    Takuma Ohashi
    Jun Kiuchi
    Keiji Nishibeppu
    Hirotaka Konishi
    Atsushi Shiozaki
    Ryo Morimura
    Hisashi Ikoma
    Toshiya Ochiai
    Kazuma Okamoto
    Hiroki Taniguchi
    Eigo Otsuji
    Scientific Reports, 7
  • [9] Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer
    Imamura, Taisuke
    Komatsu, Shuhei
    Ichikawa, Daisuke
    Miyamae, Mahito
    Okajima, Wataru
    Ohashi, Takuma
    Kiuchi, Jun
    Nishibeppu, Keiji
    Konishi, Hirotaka
    Shiozaki, Atsushi
    Morimura, Ryo
    Ikoma, Hisashi
    Ochiai, Toshiya
    Okamoto, Kazuma
    Taniguchi, Hiroki
    Otsuji, Eigo
    SCIENTIFIC REPORTS, 2017, 7